Insight Molecular Diagnostics (IMDX) Retained Earnings (2016 - 2026)
Insight Molecular Diagnostics' Retained Earnings history spans 7 years, with the latest figure at -$400.8 million for Q4 2025.
- On a quarterly basis, Retained Earnings fell 1908485.71% to -$400.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$400.8 million, a 1908485.71% decrease, with the full-year FY2025 number at -$400.8 million, down 1908485.71% from a year prior.
- Retained Earnings hit -$400.8 million in Q4 2025 for Insight Molecular Diagnostics, down from $86000.0 in the prior quarter.
- Over the last five years, Retained Earnings for IMDX hit a ceiling of $86000.0 in Q3 2025 and a floor of -$400.8 million in Q4 2025.
- Historically, Retained Earnings has averaged -$116.3 million across 5 years, with a median of -$63.8 million in 2021.
- The widest YoY moves for Retained Earnings: up 129.73% in 2025, down 1908485.71% in 2025.
- Tracing IMDX's Retained Earnings over 5 years: stood at $37000.0 in 2021, then increased by 5.41% to $39000.0 in 2022, then grew by 25.64% to $49000.0 in 2023, then plummeted by 57.14% to $21000.0 in 2024, then crashed by 1908485.71% to -$400.8 million in 2025.
- Business Quant data shows Retained Earnings for IMDX at -$400.8 million in Q4 2025, $86000.0 in Q3 2025, and $85000.0 in Q2 2025.